Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -33.73%152.68M | -28.33%115.06M | -40.51%45.44M | 44.40%302.27M | 77.60%230.4M | 78.07%160.53M | 147.11%76.37M | 88.77%209.33M | 190.25%129.73M | 223.76%90.15M |
| Operating revenue | -33.73%152.68M | -28.33%115.06M | -40.51%45.44M | 44.40%302.27M | 77.60%230.4M | 78.07%160.53M | 147.11%76.37M | 88.77%209.33M | 190.25%129.73M | 223.76%90.15M |
| Total operating cost | -12.77%186.36M | -14.01%126.02M | -19.10%54.18M | -3.68%283.52M | 9.75%213.65M | 7.88%146.55M | 18.93%66.97M | 64.50%294.35M | 79.11%194.66M | 85.85%135.85M |
| Operating cost | -28.82%96.05M | -20.51%73.37M | -22.62%28.84M | 12.71%174.21M | 41.23%134.94M | 34.10%92.3M | 51.33%37.27M | 108.28%154.56M | 260.49%95.54M | 294.31%68.83M |
| Operating tax surcharges | -36.27%713.87K | -37.75%501.58K | 30.04%257.93K | 108.36%1.39M | 501.20%1.12M | 309.65%805.81K | 82.12%198.35K | 54.48%664.73K | -83.09%186.31K | -61.86%196.71K |
| Operating expense | 18.81%10.03M | 2.96%5.49M | -19.04%2.61M | -5.40%12.86M | -4.29%8.44M | -7.41%5.33M | -6.78%3.22M | -9.13%13.59M | -28.75%8.82M | -25.60%5.76M |
| Administration expense | 9.47%34.5M | 5.39%23.19M | 0.69%10.58M | -19.87%42.35M | -19.87%31.52M | -17.56%22M | -7.82%10.51M | 23.01%52.86M | 32.45%39.33M | 30.64%26.69M |
| Financial expense | 23.05%1.88M | 52.84%1.14M | 298.92%442.55K | 3,289.51%2.1M | 1,719.59%1.53M | 283.64%748.44K | -13.80%110.94K | 103.00%61.98K | 104.79%84.18K | 113.00%195.09K |
| -Interest expense (Financial expense) | 18.38%3.12M | 7.15%1.92M | 34.67%887.64K | -0.98%3.53M | 29.02%2.63M | 43.86%1.79M | -38.27%659.15K | -2.05%3.57M | -26.30%2.04M | -24.01%1.25M |
| -Interest Income (Financial expense) | 7.55%-1.31M | 20.39%-843.56K | 21.97%-434.48K | 48.17%-1.83M | 52.02%-1.42M | 48.38%-1.06M | 41.19%-556.82K | 39.89%-3.53M | 34.89%-2.96M | 34.89%-2.05M |
| Research and development | 19.60%43.17M | -11.97%22.34M | -26.91%11.45M | -30.30%50.61M | -28.79%36.1M | -25.78%25.37M | -5.59%15.66M | 49.92%72.61M | 24.37%50.7M | 20.12%34.18M |
| Credit Impairment Loss | -1,398.41%-13.13M | -532.44%-8.57M | 2.43%-174.96K | -230.93%-8.29M | -108.42%-876.01K | -111.69%-1.35M | -102.85%-179.33K | 143.90%6.33M | 462.72%10.41M | 5,062.24%11.59M |
| Asset Impairment Loss | 31.68%-6.44M | 44.59%-3.25M | -3.03%-2.62M | 62.93%-8.53M | 41.63%-9.42M | 64.19%-5.87M | 10.14%-2.55M | -187.11%-23M | -407.30%-16.14M | -538.47%-16.39M |
| Other net revenue | ||||||||||
| Asset deal income | -99.02%10.18K | -99.15%8.33K | ---- | 210.85%1.04M | 210.57%1.04M | 198.91%980.99K | --9.63K | 602.72%334.38K | --334.38K | --328.19K |
| Other revenue | 65.22%4.98M | 35.15%2.14M | 35.07%947.12K | -15.80%4.39M | -15.08%3.01M | -50.71%1.58M | -75.18%701.19K | 67.79%5.21M | 75.65%3.55M | 122.98%3.21M |
| Operating profit | -559.52%-48.25M | -321.43%-20.64M | -243.39%-10.59M | 107.66%7.37M | 115.72%10.5M | 119.85%9.32M | 138.61%7.39M | -10.10%-96.14M | 1.82%-66.78M | -0.72%-46.95M |
| Add:Non operating Income | -99.99%0.54 | -99.98%0.49 | -59.34%0.37 | 4,483.40%154.72K | 261.17%4.72K | 122.06%2.9K | -85.46%0.91 | -99.90%3.38K | -99.96%1.31K | -99.96%1.31K |
| Less:Non operating expense | -97.87%3.34K | -99.72%436.05 | -99.51%251.65 | 21.97%223.94K | 559.84%156.49K | 5,265.88%156.49K | --51.04K | --183.61K | --23.72K | --2.92K |
| Total profit | -566.29%-48.26M | -325.14%-20.64M | -244.39%-10.59M | 107.58%7.3M | 115.49%10.35M | 119.53%9.17M | 138.35%7.34M | -14.54%-96.32M | -2.82%-66.8M | -7.66%-46.95M |
| Less:Income tax cost | 40.23%-372.34K | -60.25%-725.28K | 291.72%48.8K | -72,239.21%-4.34M | ---622.95K | ---452.59K | ---25.45K | -100.17%-6K | ---- | ---- |
| Net profit | -536.43%-47.89M | -307.01%-19.92M | -244.56%-10.64M | 112.08%11.64M | 116.42%10.97M | 120.49%9.62M | 138.48%7.36M | -9.79%-96.32M | -4.22%-66.8M | -8.57%-46.95M |
| Net profit from continuing operation | -536.43%-47.89M | -307.01%-19.92M | -244.56%-10.64M | 112.08%11.64M | 116.42%10.97M | 120.49%9.62M | 138.48%7.36M | -9.79%-96.32M | -4.22%-66.8M | -8.57%-46.95M |
| Net profit of parent company owners | -536.43%-47.89M | -307.01%-19.92M | -244.56%-10.64M | 112.08%11.64M | 116.42%10.97M | 120.49%9.62M | 138.48%7.36M | -9.79%-96.32M | -4.22%-66.8M | -8.57%-46.95M |
| Earning per share | ||||||||||
| Basic earning per share | -550.00%-0.63 | -300.00%-0.26 | -240.00%-0.14 | 111.81%0.15 | 115.91%0.14 | 120.97%0.13 | 140.00%0.1 | -10.43%-1.27 | -4.76%-0.88 | -8.77%-0.62 |
| Diluted earning per share | -550.00%-0.63 | -300.00%-0.26 | -240.00%-0.14 | 111.90%0.15 | 115.91%0.14 | 120.97%0.13 | 140.00%0.1 | -9.57%-1.26 | -4.76%-0.88 | -8.77%-0.62 |
| Other composite income | ||||||||||
| Total composite income | -307.01%-19.92M | -244.56%-10.64M | 112.08%11.64M | 120.49%9.62M | 138.48%7.36M | -9.79%-96.32M | -4.22%-66.8M | -8.57%-46.95M | ||
| Total composite income of parent company owners | ---- | -307.01%-19.92M | -244.56%-10.64M | 112.08%11.64M | ---- | 120.49%9.62M | 138.48%7.36M | -9.79%-96.32M | -4.22%-66.8M | -8.57%-46.95M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.